Genentech - A Member of the Roche Group

Rigorous Research. Amazing Discoveries.

We're passionate about helping people combat the world's hardest-to-treat diseases. So we constantly challenge ourselves to expand our scientific expertise, increase our technological understanding, and pursue our passion. To us, science is personal.
Read Our Vision

Met Explained

PlayPlay03:57

Genentech scientist Bob Yauch explains the role of the Met signaling pathway in cancer, and how investigational medicines are targeting the pathway.

Valentines for Nerds

Check out our collection of biotech #nerdlove valentine cards on Pinterest.

The HER Pathway and Cancer

Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.

Breakthrough Alliance

Array biopharma and Genentech's strategic alliance was voted Breakthrough Alliance of 2012. Partner with us.

How to Get Into the Brain

Learn how Genentech scientists developed a new way to get medicines through the blood-brain barrier.

Get to Know Us

How well do you know Genentech? Learn about who we are outside of the lab.

Request for Research Materials

We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.

Work Life

Our people love working here, and it shows.

FORTUNE Best Company

We've been named to FORTUNE's "100 Best Companies to Work For" list for the 15th year in a row.

Rigorous and Groundbreaking Science

We're passionate about combatting the hardest-to-treat diseases. Learn about our research vision.

Understanding Biomarkers

Jeff Settleman explains how biomarkers identify which patients may benefit from certain treatments.

A Patient-centric Approach

Here's how we put patients at the heart of everything we do.

Our Pipeline

The Genentech Research and Early Development pipeline has 30 new molecular entities in clinical development.

Meet our Scientists

Scientists are at the core of our business. Learn about what inspires them every day.

Taking Science Personally

Our scientists discuss their rigorous approach to breakthrough science.

The RAS-RAF Pathway

Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.

Scientific Research Board

An advisory group to the company around research and early development projects.

Bay Area Top Employer

The San Francisco Business Times named us one of 2012's "Best Places to Work in the Bay Area."

Clinical Fellowships

Our immunology program offers the experience needed to transform knowledge into practice

Support for Scientific Projects

We provide funding for general research, translational research, and other development projects.
Load More  

2012 Publishing, Genentech Research & Early Development

435
TOTAL PUBLICATIONS
28
PUBLICATIONS IN NATURE JOURNALS
31
POSTDOC PUBLICATIONS